#Biomarker, Cancer Detection, Cyted Health, EQT Life Sciences, Expansion, HealthTech, Molecular Diagnostics, Series B
2 articles with this tag
Funding Round
Cyted Health Raises €37.5M Series B for Oesophageal Cancer Diagnostics
Cyted Health secured €37.5 million in Series B financing. EQT Life Sciences, Advent Life Sciences, and British Business Bank led the round. This funding will accelerate the company's US expansion for its oesophageal cancer diagnostics.
7 months ago
Funding Round
Cyted Health Raises €37.5M Series B for Oesophageal Cancer Diagnostics
Cambridge-based Cyted Health secured €37.5 million in its Series B financing. EQT Life Sciences, Advent Life Sciences, and British Business Bank led the round.
7 months ago